Suppr超能文献

标准与加速角膜交联术治疗圆锥角膜的比较:一项荟萃分析。

Comparison of standard and accelerated corneal cross-linking for the treatment of keratoconus: a meta-analysis.

机构信息

Department of Ophthalmology, Goethe-University, Frankfurt, Germany.

Department of Ophthalmology, Medical University of Graz, Graz, Austria.

出版信息

Acta Ophthalmol. 2019 Feb;97(1):e22-e35. doi: 10.1111/aos.13814. Epub 2018 May 31.

Abstract

PURPOSE

To compare results between standard and accelerated corneal collagen cross-linking (CXL) for the treatment of progressive keratoconus.

METHODS

We performed literature searches in PubMed, Cochrane Library, Web of Science, ISRCTN registry, ClinicalTrials.gov, and EMBASE for studies comparing conventional Dresden (C-CXL) and accelerated CXL (A-CXL). Outcomes were clinical results and changes in corneal properties. Weighted mean differences were used to evaluate the effects.

RESULTS

Here, 22 studies with 1158 eyes (C-CXL: 577 eyes; A-CXL: 581 eyes) were included. At the last follow-up, C-CXL was superior regarding minimum keratometry (p < 0.00001) and demarcation line depth (p < 0.00001), whereas A-CXL should be favoured when considering minimum corneal thickness (p = 0.0005). No differences in uncorrected and corrected distance visual acuity (p = 0.09 and 0.98), spherical equivalent (p = 0.11), spherical and cylindrical error (p = 0.29 and 0.32), maximal and average keratometry (p = 0.05 and 0.65), central corneal thickness (p = 0.15), corneal biomechanical properties (p ≥ 0.21 respectively), time of reepithelialization (p = 0.76), subbasal nerve density (p = 0.69), endothelial cell density (p = 0.30) and morphology (p ≥ 0.40 respectively) were found among both groups.

CONCLUSION

Consideration of less corneal thinning favours A-CXL, whereas the deeper demarcation line and greater changes in minimum keratometric values in C-CXL may indicate a higher treatment efficacy. Altogether, C-CXL, as well as A-CXL, provides successful results in the strengthening of corneal tissue.

摘要

目的

比较标准和加速角膜胶原交联(CXL)治疗进行性圆锥角膜的效果。

方法

我们在 PubMed、Cochrane 图书馆、Web of Science、ISRCTN 注册处、ClinicalTrials.gov 和 EMBASE 中进行了文献检索,以比较传统的德累斯顿(C-CXL)和加速 CXL(A-CXL)。评估的结果为临床结果和角膜特性的变化。使用加权均数差来评估效果。

结果

共纳入 22 项研究,共 1158 只眼(C-CXL:577 只眼;A-CXL:581 只眼)。在最后一次随访时,C-CXL 在最小角膜曲率(p < 0.00001)和分界线深度(p < 0.00001)方面更优,而在考虑最小角膜厚度时,A-CXL 应该更有利(p = 0.0005)。未矫正和矫正的远视力(p = 0.09 和 0.98)、等效球镜(p = 0.11)、球镜和柱镜误差(p = 0.29 和 0.32)、最大和平均角膜曲率(p = 0.05 和 0.65)、中央角膜厚度(p = 0.15)、角膜生物力学特性(p ≥ 0.21)、上皮再植时间(p = 0.76)、基底神经密度(p = 0.69)、内皮细胞密度(p = 0.30)和形态(p ≥ 0.40)在两组之间均无差异。

结论

考虑到角膜变薄较少,A-CXL 更有利,而 C-CXL 的分界线更深,最小角膜曲率值的变化更大,可能表明治疗效果更高。总的来说,C-CXL 和 A-CXL 都能成功增强角膜组织。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验